Envoy Medical, Inc.
COCH
$0.66
$0.034.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -48.00% | 78.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -48.00% | 78.57% | |||
| Cost of Revenue | 1,390.48% | -89.66% | |||
| Gross Profit | -607.41% | 133.54% | |||
| SG&A Expenses | 20.46% | -40.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.34% | 9.04% | |||
| Operating Income | 3.81% | -8.53% | |||
| Income Before Tax | 33.94% | -1.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.94% | -1.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.94% | -1.60% | |||
| EBIT | 3.81% | -8.53% | |||
| EBITDA | 3.74% | -8.58% | |||
| EPS Basic | 62.36% | 23.33% | |||
| Normalized Basic EPS | 71.94% | 24.27% | |||
| EPS Diluted | 62.36% | 23.33% | |||
| Normalized Diluted EPS | 71.94% | 24.27% | |||
| Average Basic Shares Outstanding | 142.13% | 30.29% | |||
| Average Diluted Shares Outstanding | 142.13% | 30.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||